Federal Register / Vol. 66, No. 32 / Thursday, February 15, 2001 / Notices 10505

§ 225.28(b)(3) of the Board’s Regulation

Y.

Board of Governors of the Federal Reserve

System, February 9, 2001.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 01–3793 Filed 2–14–01; 8:45 am]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

White House Commission on

Complementary and Alternative

Medicine Policy; Notice of Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is given of a meeting of the White House

Commission on Complementary and

Alternative Medicine Policy.

The purpose of the meeting is to

convene the Commission for a public

hearing to receive public testimony for

individuals and organizations interested

in the subject of Federal policy

regarding complementary and

alternative medicine. The major focus of

the meeting is on the education,

training, and licensing and credentialing

of all health care practitioners engaged

in the delivery of complementary and

alternative medicine (CAM) practices

and products. Comments received at the

meeting may be used by the

Commission to prepare the Report to the

President as required by the Executive

Order.

Comments should focus on the

education and training of health care

practitioners in complementary and

alternative medicine. Invited speaker

discussions include the following:

Establishing CAM educational and

training programs; Continuing CAM

education and training; Assuring quality

and accountability in CAM practice; and

Credentialing and licensing of CAM

practice. The discussion also may focus

on the following questions:

(1) Can uniform standards of

education, training, licensing, and

certification be applied to all

practitioners?

(2) What training and education

should be required of all practitioners to

assure access to safe and effective CAM

practices and products?

(3) What sources of funds exist for the

education and training of all

practitioners delivery of CAM practices

and products?

(4) Are performance standards or

practice guidelines needed to assure the

public will have access to the full range

of safe and effective CAM practices and

products?

Some Commission members may

participate by telephone conference.

Opportunities for oral statements by the

public will be provided on February 23,

from about 4 p.m.–5:30 p.m. (Time

approximate).

Name of Committee: The White House

Commission on Complementary and

Alternative Medicine Policy.

Date: February 22—23, 2001.

Time: February 22—8:15 a.m.–5:45 p.m.

February 23—8:15 a.m.–5:30 p.m.

Place: Hubert H. Humphrey Building,

Room 800, 200 Independence Avenue, SW.,

Washington, DC 20201.

Contact Persons: Michele M. Chang, CMT,

MPH, Executive Secretary, or, Stephen C.

Groft, Pharm.D., Executive Director, 6701

Rockledge Drive, Room 1010, MSC 7707,

Bethesda, MD 20817–7707, Phone: (301)

435–7592, Fax: (301) 480–1691, E-mail:

WHCCAMP@mail.nih.gov.

Because of the need to obtain the

views of the public on these issues as

soon as possible and because of the

early deadline for the report required of

the Commission, this notice is being

provided at the earliest possible time.

SUPPLEMENTARY INFORMATION: The

President established the White House

Commission on Complementary and

Alternative Medicine Policy on March

7, 2000, by Executive Order 13147. The

mission of the White House

Commission on Complementary and

Alternative Medicine Policy is to

provide a report, through the Secretary

of the Department of Health and Human

Services, on legislative and

administrative recommendations for

assuring that public policy maximizes

the benefits of complementary and

alternative medicine to Americans.

Public Participation

The meeting is open to the public

with attendance limited by the

availability of space on a first come first

serve basis. Members of the public who

wish to present oral comment may

register no later than February 19, 2001,

by completing the on-line registration

form at the Commission’s website or

faxing a request to 301–480–1691.

Additional information, including

agenda item topics, for the meeting can

be found on the website of the

Commission at http://whccamp.hhs.gov.

Oral comments will be limited to

three minutes. Individuals who register

to speak will be assigned in the order in

which they registered. Due to time

constraints, only one representative

from each organization will be allotted

time for oral testimony. The number of

speakers and the time allotted may also

be limited by the number of registrants.

All requests to register should include

the name, address, telephone number,

and business or professional affiliation

of the interested party, and should

indicate the area of interest or question

(as described above) to be addressed.

Any person attending the meeting

who has not registered to speak in

advance of the meeting will be allowed

to make a brief oral statement during the

time set aside for public comment if

time permits, and at the Chairperson’s

discretion. Individuals unable to attend

the meeting, or any interested parties,

may send written comments by mail,

fax, or electronically to the staff office

of the Commission for inclusion in the

public record.

When mailing or faxing written

comments provide, if possible, an

electronic version on diskette. Persons

needing special assistance, such as sign

language interpretation or other special

accommodations, should contact the

Commission staff at the address or

telephone number listed no later than

February 16, 2001.

Dated: February 8, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3815 Filed 2–14–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN FOCUS

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: April 3, 2001.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

10506 Federal Register / Vol. 66, No. 32 / Thursday, February 15, 2001 / Notices

Place: Natcher Building, Room 5As.25,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: John R. Lymangrover, PhD,

Scientific Review Administrator, National

Institutes of Health, NIAMS, Natcher Bldg.,

Room 5As25N, Bethesda, MD 20892, 301–

594–4952.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.846, Arthritis,

Musculoskeletal and Skin Diseases Research,

National Institutes of Health, HHS)

Dated: February 8, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3816 Filed 2–14–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, a

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: March 16, 2001.

Time: 8 a.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: Ramada Inn, 1775 Rockville Pike,

Rockville, MD 20852.

Contact Person: Richard J Bartlett, PhD,

Scientific Review Administrator, National

Institute of Arthritis and Musculoskeletal and

Skin Diseases, Natcher Bldg./Bldg. 45, Room

5As37B, (301) 594–4952.

(Catalogue of Federal Domestic Assistance

Program No. 93.846, Arthritis,

Musculoskeletal and Skin Diseases Research,

National Institutes of Health, HHS)

Dated: February 8, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3817 Filed 2–14–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: April 16, 2001.

Time: 8:30 a.m. to 4:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20853.

Contact Person: Tracy A. Shahan, PhD,

Scientific Review Administrator, National

Institutes of Health/NIAMS, Natcher Bldg.,

Room 5AS25H, Bethesda, MD 20892, (301)

594–4952.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.846, Arthritis,

Musculoskeletal and Skin Diseases Research,

National Institutes of Health, HHS)

Dated: February 8, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3818 Filed 2–14–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Arthritis and Musculoskeletal and Skin

Diseases Special Emphasis Panel.

Date: March 5, 2001.

Time: 8:30 a.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Richard J. Bartlett, PhD,

Scientific Review Administrator, National

Institute of Arthritis and Musculoskeletal and

Skin Diseases, Natcher Bldg./Bldg. 45, Room

5As37B, (301) 594–4952.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.846, Arthritis,

Musculoskeletal and Skin Diseases Research,

National Institutes of Health, HHS)

Dated: February 8, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3819 Filed 2–14–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF THE INTERIOR

Fish and Wildlife Service

Notice of Intent To Prepare

Comprehensive Conservation Plans

and an Associated Environmental

Impact Statement

ACTION: Notice of intent to prepare

comprehensive conservation plans and

an associated environmental impact

statement for island units of the eastern

Massachusetts national wildlife refuge

complex.

SUMMARY: This notice advises the public

that the U.S. Fish and Wildlife Service